AVCN.TO · Avicanna Inc.
Canada · RS rating 8 · As of 2026-10-14
| Price | 0.10 CAD |
|---|---|
| 1-day change | -13.0% |
| RS rating (overall / 1M / 3M / 12M) | 8 / 19 / 15 / 6 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 15 / 16 |
| Industry group (rank) | Medical-Generic Drugs (45) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -15.6% |
| Distance from 52-week high | +66.1% |
| Market cap (USD) | $10.9M |